IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,722,480 | -34.0% | 3,169,164 | 0.0% | 0.37% | -36.1% |
| Q2 2023 | $20,789,716 | +90.1% | 3,169,164 | 0.0% | 0.58% | +44.8% |
| Q1 2023 | $10,933,616 | +64.2% | 3,169,164 | +26.6% | 0.40% | +42.3% |
| Q4 2022 | $6,658,169 | -25.1% | 2,503,071 | 0.0% | 0.28% | -23.4% |
| Q3 2022 | $8,886,000 | -19.9% | 2,503,071 | 0.0% | 0.37% | -31.5% |
| Q2 2022 | $11,089,000 | -27.3% | 2,503,071 | +0.1% | 0.54% | -12.1% |
| Q1 2022 | $15,260,000 | -32.3% | 2,501,571 | +39.1% | 0.61% | -25.5% |
| Q4 2021 | $22,552,000 | -2.5% | 1,798,371 | -1.8% | 0.82% | -9.2% |
| Q3 2021 | $23,121,000 | -6.8% | 1,832,071 | +3.7% | 0.90% | -3.0% |
| Q2 2021 | $24,814,000 | -45.1% | 1,767,399 | +10.5% | 0.93% | -45.1% |
| Q1 2021 | $45,190,000 | – | 1,599,658 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |